FDA Inspection 1007879 — Pinky Agarwal MD
The FDA completed an inspection of Pinky Agarwal MD on April 10, 2017 in Kirkland, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 10, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Kirkland, WA (United States)
Additional Details
Clinical Investigator (CI)